Miramar R&D Tax Credit Benefits for Businesses

R&D Tax Credits for Miramar, Florida Businesses

Miramar, Florida, is known for its strong presence in healthcare, education, retail, and logistics. Top companies in the city include Memorial Healthcare System, a major healthcare provider; Broward College, a key educational institution; Walmart, a global retail giant; Amazon, a global logistics and e-commerce company; and FedEx, a key logistics company. The R&D Tax Credit can help these industries reduce tax liabilities, encourage innovation, and enhance business performance. By utilizing the R&D Tax Credit, companies can reinvest savings into advanced research driving growth and competitiveness in Miramar’s economy.

Find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 13727 SW 152 Street, Miami is less than 25 miles from Miramar and provides R&D tax credit consulting and advisory services to Miramar and the surrounding areas such as: Fort Lauderdale, Pembroke Pines, Hollywood, Miami Gardens and Davie.

If you have any questions or need further assistance, please call or email our local Miami Partner on (786) 404-1316.
Feel free to book a quick teleconference with one of our Florida R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Miramar, Florida Patent of the Year – 2024/2025

Hcw Biologics Inc. has been awarded the 2024/2025 Patent of the Year for its groundbreaking multi-chain chimeric polypeptide platform. Their invention, detailed in U.S. Patent No. 11884712, titled ‘Multi-chain chimeric polypeptides and uses thereof’, utilizes engineered protein chains that assemble through affinity domains to enhance immune system targeting.

The patented technology comprises two distinct polypeptides. One includes a target-binding domain, a soluble tissue factor domain, and an affinity domain. The other features a complementary affinity domain and a second target-binding domain. These components associate via their affinity domains, forming a functional complex capable of precise immune modulation.

This modular design allows for customizable therapeutic agents, potentially improving treatments for cancer, autoimmune disorders, and age-related diseases. By facilitating targeted immune responses, the platform aims to increase efficacy while reducing side effects.

Hcw Biologics, led by inventor Hing Wong, focuses on developing innovative immunotherapies. This patent exemplifies their commitment to advancing healthcare through cutting-edge biotechnology.